Human medicines European public assessment report (EPAR): Olanzapine Viatris (previously Olanzapine Mylan), olanzapine, Date of authorisation: 06/10/2008, Revision: 23, Status: Authorised

Nominations to the Network Portfolio Advisory Group

Human medicines European public assessment report (EPAR): Norvir, ritonavir, Date of authorisation: 25/08/1996, Revision: 72, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxinact H5, Avian influenza virus, subtype H5, haemagglutinin (recombinant), Status: Authorised

EMA workshop: Non-clinical data for regulatory decision-making on the efficacy of medical countermeasures, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 November 2025, 09:00 (CET) to 25 November 2025, 16:00 (CET)

Report - Industry stakeholders' feedback on engagement and communication activities

Human medicines European public assessment report (EPAR): Voraxaze, glucarpidase, Date of authorisation: 11/01/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Kuvan, sapropterin, Date of authorisation: 02/12/2008, Revision: 22, Status: Authorised

Highlight report - Combination Products Operational Group (COMBO) - Medical Devices stream

Highlight report - Combination Products Operational Group (COMBO) - In Vitro Diagnostics stream